 | ChromaDex (NASDAQ:CDXC) Price Target Raised to $18.00
americanbankingnews.com - March 9 at 4:28 AM |
 | ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board - Business Wire
businesswire.com - March 8 at 8:12 PM |
 | ChromaDex (CDXC) Surges 12%: Is This an Indication of Further Gains? - Yahoo Finance
finance.yahoo.com - March 8 at 10:10 AM |
| ChromaDex (CDXC) Surges 12%: Is This an Indication of Further Gains?
finance.yahoo.com - March 8 at 10:10 AM |
| ChromaDex (NASDAQ:CDXC) Trading Up 12%
americanbankingnews.com - March 5 at 6:42 PM |
| ChromaDex (NASDAQ:CDXC) Trading Down 16%
americanbankingnews.com - March 4 at 9:35 PM |
 | US$23.45 - That's What Analysts Think ChampionX Corporation (NASDAQ:CHX) Is Worth After These Results - Nasdaq
nasdaq.com - March 4 at 6:43 AM |
| ChromaDex (CDXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - March 3 at 1:35 PM |
| ChromaDex (CDXC) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - March 3 at 2:02 AM |
| ChromaDex (NASDAQ:CDXC) Shares Gap Up to $13.93
americanbankingnews.com - March 1 at 9:47 AM |
|
| CDXC Stock: Why ChromaDex Shares Are Rocketing Higher Today - Nasdaq
nasdaq.com - February 27 at 8:09 AM |
 | Form SC 13G ChromaDex Corp. Filed by: Yong Rong (HK) Asset Management Ltd - StreetInsider.com
streetinsider.com - February 26 at 10:08 PM |
| ChromaDex (NASDAQ:CDXC) Shares Down 25.7%
americanbankingnews.com - February 26 at 8:32 PM |
| ChromaDex Sees Unusually Large Options Volume (NASDAQ:CDXC)
americanbankingnews.com - February 25 at 1:02 PM |
| ChromaDex (NASDAQ:CDXC) Reaches New 12-Month High at $12.53
americanbankingnews.com - February 25 at 11:16 AM |
| New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients - Business Wire
businesswire.com - February 24 at 2:09 PM |
| New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients
finance.yahoo.com - February 24 at 9:08 AM |
| ChromaDex Co. (NASDAQ:CDXC) Expected to Post Earnings of -$0.11 Per Share
americanbankingnews.com - February 24 at 2:12 AM |
| ChromaDex (NASDAQ:CDXC) Shares Up 15.6%
americanbankingnews.com - February 22 at 7:01 PM |
| ChromaDex Announces $25 Million Private Placement of Common Stock - Business Wire
businesswire.com - February 22 at 2:05 PM |
| Form 8-K ChromaDex Corp. For: Feb 20 - StreetInsider.com
streetinsider.com - February 22 at 9:04 AM |
 | ChromaDex raises $25M through private placement of common stock - Seeking Alpha
seekingalpha.com - February 22 at 9:04 AM |
| ChromaDex Announces $25 Million Private Placement of Common Stock
finance.yahoo.com - February 22 at 9:04 AM |
| Is ChromaDex's (NASDAQ:CDXC) Share Price Gain Of 110% Well Earned? - Yahoo Finance
finance.yahoo.com - February 20 at 8:54 AM |
| ChromaDex to Report Fourth Quarter 2020 Financial Results on Wednesday, March 10, 2021 - Yahoo Finance
finance.yahoo.com - February 20 at 8:54 AM |
| Is ChromaDex's (NASDAQ:CDXC) Share Price Gain Of 110% Well Earned?
finance.yahoo.com - February 20 at 8:54 AM |
| ChromaDex (NASDAQ:CDXC) Hits New 52-Week High at $8.60
americanbankingnews.com - February 19 at 9:02 PM |
| ChromaDex (NASDAQ:CDXC) Shares Up 17.9%
americanbankingnews.com - February 16 at 7:18 PM |
| This Bioscience Company Is Trying To Defy The Aging Process
finance.yahoo.com - February 12 at 5:54 PM |
 | CDXC Feb 2021 2.500 call
uk.finance.yahoo.com - February 11 at 3:02 PM |
 | Thorne Research, Inc., Continues to Challenge the Validity of US Patents on Nicotinamide Riboside - PRNewswire
prnewswire.com - February 4 at 9:29 AM |
| New Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver Function - Business Wire
businesswire.com - February 4 at 9:29 AM |
|
| New Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver Function
finance.yahoo.com - February 4 at 9:29 AM |
| What You Need To Know About ChromaDex Corporation's (NASDAQ:CDXC) Investor Composition - Yahoo Finance
finance.yahoo.com - December 22 at 7:17 AM |
| What You Need To Know About ChromaDex Corporation's (NASDAQ:CDXC) Investor Composition
finance.yahoo.com - December 22 at 7:17 AM |
 | ChromaDex Corp.
barrons.com - December 20 at 10:44 PM |
| ChromaDex (CDXC) in Focus: Stock Moves 5.6% Higher - Yahoo Finance
finance.yahoo.com - December 14 at 9:36 AM |
| ChromaDex (CDXC) in Focus: Stock Moves 5.6% Higher
finance.yahoo.com - December 14 at 9:36 AM |
| ChromaDex to Present at Benzinga's Inaugural Small Cap Conference in December 2020 - Business Wire
businesswire.com - December 2 at 4:58 PM |
| Is ChromaDex (CDXC) A Good Stock To Buy Now?
finance.yahoo.com - December 2 at 4:58 PM |
| ChromaDex to Present at Benzinga’s Inaugural Small Cap Conference in December 2020
finance.yahoo.com - December 2 at 8:15 AM |
| ChromaDex initiates human clinical trial of Niagen to increase milk production among preterm mothers
seekingalpha.com - November 17 at 12:39 PM |
| ChromaDex Announces New Clinical Trial to Investigate Niagen® and Milk Production Among Mothers in the Neonatal Intensive Care Unit (NICU)
finance.yahoo.com - November 17 at 7:38 AM |
| ChromaDex and Watsons Launch New TRU NIAGEN® EX Stick Packs in Hong Kong, Expanding Product Line and Advancing Global Retail Partnership - Business Wire
businesswire.com - November 9 at 3:05 PM |
| ChromaDex and Watsons Launch New TRU NIAGEN® EX Stick Packs in Hong Kong, Expanding Product Line and Advancing Global Retail Partnership
finance.yahoo.com - November 9 at 10:04 AM |
| Chromadex: The Little Company That Could - Seeking Alpha
seekingalpha.com - November 8 at 8:08 AM |
| Earnings Update: Here's Why Analysts Just Lifted Their ChromaDex Corporation (NASDAQ:CDXC) Price Target To US$8.00 - Yahoo Finance
finance.yahoo.com - November 7 at 2:18 PM |
| Earnings Update: Here's Why Analysts Just Lifted Their ChromaDex Corporation (NASDAQ:CDXC) Price Target To US$8.00
finance.yahoo.com - November 7 at 2:18 PM |
| Have Insiders Been Buying ChromaDex Corporation (NASDAQ:CDXC) Shares?
finance.yahoo.com - November 7 at 2:18 PM |
| ChromaDex's (CDXC) CEO Rob Fried on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 7:40 AM |
